Advent International to acquire a significant stake in Suven Pharmaceuticals
Advent will also be making an open offer to acquire additional 26% of the outstanding equity shares of the company from the public shareholders.
Advent will also be making an open offer to acquire additional 26% of the outstanding equity shares of the company from the public shareholders.
As per the agreement, NSE-listed Vaishali Pharma Limited will take over the entire domestic and international marketing of Jark Pharma’s portfolio of quality based ayurvedic products
Her previous role at Novartis, where she was general manager, data & digital, in global drug development, also included accountability for driving the DCT strategy, programs and platforms
The designation recognizes Seeq's expertise in enabling faster insights and better business outcomes for life sciences customers, including Bristol Myers Squibb, with advanced analytics innovations.
China is now focusing on establishing volume and enhancing capabilities for innovative high value drug production
LG Chem will receive totaling up to $95.5 million for the China rights
This partnership stemmed from a successful customer-supplier relationship spanning several years.
Results are the first demonstration of efficacy for an investigational mRNA cancer treatment in a randomized clinical trial
Subscribe To Our Newsletter & Stay Updated